TREA

79334430 - U-LOAD

Follow

Information

  • Trademark
  • 79334430
  • Serial Number
    79334430
  • Registration Number
    7318010
  • Filing Date
    November 12, 2021
    3 years ago
  • Registration Date
    March 05, 2024
    a year ago
  • Transaction Date
    November 19, 2024
    8 months ago
  • Status Date
    March 05, 2024
    a year ago
  • Published for Opposition Date
    December 19, 2023
    a year ago
  • Location Date
    March 05, 2024
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    ALLEN, BIANCA
  • Attorney Docket Number
    6084IM-3
    Attorney Name
    Miriam D. Trudell
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
U-LOAD
Case File Statements
  • GS0051: Preparations for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes, namely, diagnostic preparations for medical purposes and medical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for medical analysis of vaccines, immunotherapeutics and cellular therapies, in particular cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy or other therapy, for medical analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases; diagnostic preparations for analysis for medical purposes, hereunder for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring
  • PM0001: YOU LOAD
  • GS0011: Chemicals used in industry and science, in the nature of immune related chemicals for immune cell analysis, immune cell monitoring, immune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research use, other than medical and veterinary use, and scientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnostic, other than medical and veterinary, purposes, namely, diagnostic reagents and preparations, except for medical or veterinary use; diagnostic kits for scientific and diagnostic, other than medical and veterinary, purposes comprised of diagnostic reagents and preparations, except for medical or veterinary use and also comprised of immune related chemicals used in science, in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non-medical purposes, other than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for use in scientific research in connection with therapy and immunotherapy, in particular, for use in cancer therapy, cancer immunotherapy, for analysis of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; chemical, and diagnostic preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in scientific research in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes
Case File Event Statements
  • 2/24/2022 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/25/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/1/2022 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/24/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/1/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/2/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/27/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/27/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/14/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/2/2023 - 2 years ago
    10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/27/2023 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/27/2023 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/3/2023 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/21/2023 - 2 years ago
    14 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/20/2023 - 2 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/20/2023 - 2 years ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/20/2023 - 2 years ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 7/26/2023 - 2 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 7/26/2023 - 2 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/14/2023 - a year ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 11/8/2023 - a year ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 11/8/2023 - a year ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/8/2023 - a year ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/8/2023 - a year ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/29/2023 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/29/2023 - a year ago
    27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/18/2023 - a year ago
    28 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 11/29/2023 - a year ago
    26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/19/2023 - a year ago
    29 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/19/2023 - a year ago
    30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/5/2024 - a year ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/6/2024 - a year ago
    33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/13/2024 - 8 months ago
    35 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/13/2024 - 8 months ago
    34 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/13/2024 - 8 months ago
    36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/5/2024 - a year ago
    32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC